Viewing Study NCT02404818


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-01-08 @ 6:54 PM
Study NCT ID: NCT02404818
Status: COMPLETED
Last Update Posted: 2022-06-10
First Post: 2015-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy
Sponsor: University of Florida
Organization:

Study Overview

Official Title: UFPTI 1431 - HL02: Investigating Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Survivors Treated With Either Photon or Proton Radiation
Status: COMPLETED
Status Verified Date: 2022-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate if radiation and chemotherapy treatment cause cardiac abnormalities among survivors of Hodgkin's lymphoma.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
IRB201703302 OTHER UF IRB-03 View